Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page
- ChecktodayChange DetectedNew revision entries appear for 2026-01-08, 2025-12-16, and 2025-12 with version v3.3.4, while older revisions including 2025-09-18, 2025-09-16, 2025-03 and v3.3.3 were removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a Locations section highlighting Massachusetts study sites (Boston) and updated the page revision to v3.3.3. The previous Massachusetts Locations grouping and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision label updated on the page: added Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding and NIH operating status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedNo additions or deletions detected; the study details and eligibility criteria appear unchanged.SummaryDifference0.5%

- Check100 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.